Formulation and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Overview

The project titled "Formulation and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy" aims to address the pressing need for more effective and targeted treatment options for cancer patients. Cancer remains a significant global health challenge, with traditional treatments such as chemotherapy often causing severe side effects due to their non-specific nature. Therefore, the development of novel drug delivery systems that can target cancer cells specifically while minimizing damage to healthy tissues is crucial for improving treatment outcomes and patient quality of life. This research project will focus on the formulation and evaluation of innovative drug delivery systems designed to target cancer cells selectively. By utilizing advanced techniques and technologies, such as nanotechnology and targeted drug delivery strategies, the project aims to enhance the efficacy of cancer therapeutics while reducing systemic toxicity. The development of these novel drug delivery systems will involve the encapsulation of anti-cancer drugs within carrier systems that can specifically target cancer cells based on their unique characteristics. The evaluation of these novel drug delivery systems will include comprehensive in vitro and in vivo studies to assess their effectiveness in targeting cancer cells, delivering therapeutic agents, and minimizing off-target effects. Various parameters, such as drug release kinetics, cellular uptake, cytotoxicity, and pharmacokinetics, will be analyzed to determine the performance and potential clinical utility of the developed drug delivery systems. Overall, this research project holds significant promise for advancing the field of cancer therapy by offering more precise and effective treatment options for patients. The development of novel drug delivery systems for targeted cancer therapy has the potential to revolutionize cancer treatment paradigms, leading to improved patient outcomes and reduced treatment-related toxicities. Through this research endeavor, we aim to contribute to the ongoing efforts to enhance cancer treatment strategies and ultimately improve the lives of individuals affected by this devastating disease.